Loading stock data…
Claritev Corporation (CTEV)
$21.61-1.66 (-7.13%)
Market ClosedLast close Jul 24
Claritev Corporation, together with its subsidiaries, provides data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the healthcare industry in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Claritev Corporation in the Healthcare sector is trading at $21.61 with a market capitalization of $521M. Wall Street consensus targets $37.67 (6 analysts), implying a +74.3% move over the next 12 months. The stock is currently near its 52-week low of $11.50, remaining 33.0% below its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the distress zone. Risk note: RSI 19 is oversold, raising the odds of a near-term bounce; MACD remains below its signal line. The Whystock Score of 70/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +74.3% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Oversold momentum (RSI 19) — potential for technical mean-reversion
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $244.68M↓ | $246.55M↑ | $245.96M↑ | $241.57M↑ | $231.33M |
| Gross Profit | $163.87M↓ | $168.52M↑ | $163.65M↑ | $162.44M↑ | $154.13M |
| Operating Income | $6.68M↓ | $8.67M↓ | $10.07M↓ | $16.58M↑ | $13.41M |
| Net Income | -$73.56M↑ | -$80.57M↓ | -$69.75M↓ | -$62.64M↑ | -$71.32M |
Peer Comparison
JNJUNHPFE
Fundamentals
Claritev Corporation, together with its subsidiaries, provides data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers claims intel...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$521.49M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Elite ROE. Management converts capital into profit efficiently.
118.82%
Volume
Today's trading volume
57,342
Recent News
UnitedHealth Group (UNH) Stock Still Looks Cheap Following Raised 2026 Outlook
UnitedHealth Group stock has delivered a 54.8% return over the past year, yet the broader valuation checks point to a mixed picture rather than a straightforward bargain or clear overvaluation. UnitedHealth Group's 54.8% gain over the last 12 months puts recent buyers in a strong position, but it also raises the bar for what counts as good value from here. On the positive side, recent earnings strength and margin improvements can support the case that the current price still reflects...
UnitedHealth Group (UNH) Faces Wider DOJ Antitrust Probe As Claritev Review Expands
The U.S. Department of Justice has expanded an antitrust investigation to include UnitedHealth Group's Claritev unit. The Claritev review is part of broader DOJ scrutiny of healthcare industry practices and market competition. This development adds a fresh layer of regulatory attention for UnitedHealth Group (NYSE:UNH) beyond routine oversight. UnitedHealth Group, one of the largest managed care and healthcare services companies in the U.S., spans insurance, care delivery, and data-driven...
Sector Update: Healthcare Stocks Fall Late Afternoon
Healthcare stocks fell late Tuesday afternoon with the NYSE Healthcare Index declining 1.7% and the
Update: Market Chatter: DOJ Expands Antitrust Probe Into Claritev
(Updates with Claritev's response in the fourth paragraph.) The US Justice Department recently se
Strength Seen in Evolent Health (EVH): Can Its 9.5% Jump Turn into More Strength?
Evolent Health (EVH) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.